3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
4
Recruiting
4
Completed
2
Active not recruiting
2
Withdrawn
1
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
34
Small Cell Lung Carcinoma
14
Triple Negative Breast Neoplasms
12
Breast Neoplasms
9
Ovarian Neoplasms
8
Lung Neoplasms
7
Endometrial Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Esophageal Neoplasms
4
NSCLC
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Recurrence
2
Neoplasms
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Brain Neoplasms
2
Unresectable Locally Advanced or Metastatic Solid Tumors
1
Thymoma
1
Thymic epithelial tumor
1
Stomach Neoplasms
1
Stage III and IV Ovarian Cancer
1
Squamous Non-small Cell Lung Cancer
1
Squamous NSCLC
1
Solid Tumor Cancer
1
Solid Tumor
1
Salivary Gland Malignant Neoplasms
1
Respiratory Tract Neoplasms
1
Interventions
pembrolizumab
1
durvalumab
1
Paclitaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Respiratory Tract Neoplasms
×
Carboplatin
×
Clear all
NCT07247786
2026-05-05
MIGRANT
Fundación GECP
Phase 2
Not yet recruiting
68 enrolled